Details for New Drug Application (NDA): 050118
✉ Email this page to a colleague
NDA 050118 describes PROSTAPHLIN, which is a drug marketed by Apothecon and is included in two NDAs. Additional details are available on the PROSTAPHLIN profile page.
The generic ingredient in PROSTAPHLIN is oxacillin sodium. There are thirty-eight drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the oxacillin sodium profile page.
The generic ingredient in PROSTAPHLIN is oxacillin sodium. There are thirty-eight drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the oxacillin sodium profile page.
Summary for 050118
| Tradename: | PROSTAPHLIN |
| Applicant: | Apothecon |
| Ingredient: | oxacillin sodium |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 050118
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | EQ 500MG BASE | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
